HBSAG LEVELS DURING ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B: PEGINTERFERON VERSUS ENTECAVIR

被引:1
|
作者
Reijnders, J. G. P. [1 ]
Rijckborst, V. [1 ]
Sonneveld, M. J. [1 ]
Scherbeijn, S. M. J. [1 ]
Boucher, C. A. B. [1 ]
Hansen, B. E. [1 ]
Janssen, H. L. A. [1 ]
机构
[1] Erasmus MC Univ Med Ctr, Rotterdam, Netherlands
关键词
D O I
10.1016/S0168-8278(10)61022-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S395 / S395
页数:1
相关论文
共 50 条
  • [41] Peginterferon Reduces Intrahepatic HBsAg and is Associated with Histologic Response in Chronic Hepatitis B
    Arends, Pauline
    Rijckborst, Vincent
    Sonneveld, Milan J.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2012, 56 : 381A - 381A
  • [42] Analysis of innate and adaptive host immunity during combination therapy with peginterferon Lambda-1a and Entecavir in patients with HBeAg(+) chronic hepatitis B
    Phillips, Sandra
    Mistry, Sameer
    Riva, Antonio
    Cooksley, Helen
    Zeuzem, Stefan
    Woffendin, Clive
    Chen, Pei-Jer
    Peng, Cheng-Yuan
    Chang, Ting-Tsung
    Lueth, Stefan
    de Knegt, Robert J.
    Choi, Moon Seok
    Wedemeyer, Heiner
    Dao, Michael
    Kim, Chang Wook
    Chu, Heng C.
    Wind-Rotolo, Megan
    Williams, Roger
    Cooney, Elizabeth L.
    Chokshi, Shilpa
    HEPATOLOGY, 2014, 60 : 308A - 309A
  • [43] Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B
    Hagiwara, Satoru .
    Nishida, Naoshi
    Ida, Hiroshi
    Ueshima, Kazuomi
    Minami, Yasunori
    Takita, Masahiro
    Komeda, Yoriaki
    Kudo, Masatoshi
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (10) : 1804 - 1810
  • [44] Early prediction of response to peginterferon for HBeAg-positive chronic hepatitis B using HBsAg levels at week 4 and week 8 of therapy
    Sonneveld, Milan J.
    Brouwer, Willem Pieter
    Zeuzem, Stefan
    Cakaloglu, Yilmaz
    Tabak, Fehmi
    Simon, Krzysztof
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2015, 62 : 1182A - 1182A
  • [45] Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B
    Heijtink, RA
    Kruining, J
    Honkoop, P
    Kuhns, MC
    Hop, WCJ
    Osterhaus, ADME
    Schalm, SW
    JOURNAL OF MEDICAL VIROLOGY, 1997, 53 (03) : 282 - 287
  • [46] The effect of thymopentin add-on in hepatitis B e antigen positive chronic hepatitis B after virus suppression by peginterferon plus entecavir therapy
    Ma, Yanpin
    Bao, Xuli
    Xiong, Fang
    Wang, Jinhuan
    Gu, Na
    Guo, Jia
    Wu, Huili
    Lv, Jun
    CELLULAR AND MOLECULAR BIOLOGY, 2019, 65 (02) : 75 - 81
  • [47] The Role of Quantitative HBsAg Levels in Chronic Hepatitis B
    Tekin, Merve Kilic
    Surme, Serkan
    Yildirim, Mustafa
    ISTANBUL MEDICAL JOURNAL, 2024, 25 (03): : 229 - 235
  • [48] The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patients
    Kurihara, Mio
    Tsuge, Masataka
    Murakami, Eisuke
    Mori, Nami
    Ohishi, Waka
    Uchida, Takuro
    Fujino, Hatsue
    Nakahara, Takashi
    Abe-Chayama, Hiromi
    Kawaoka, Tomokazu
    Miki, Daiki
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Zhang, Yizhou
    Makokha, Grace Naswa
    Hayes, C. Nelson
    Chayama, Kazuaki
    ANTIVIRAL THERAPY, 2018, 23 (03) : 239 - 248
  • [49] Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B
    Masanari Kosaka
    Hatsue Fujino
    Masataka Tsuge
    Kenji Yamaoka
    Yasutoshi Fujii
    Shinsuke Uchikawa
    Atsushi Ono
    Eisuke Murakami
    Tomokazu Kawaoka
    Daiki Miki
    Clair Nelson Hayes
    Seiya Kashiyama
    Sho Mokuda
    Shinichi Yamazaki
    Shiro Oka
    Journal of Gastroenterology, 2025, 60 (4) : 469 - 478
  • [50] IMPACT OF PRE-TREATMENT SERUM HBV DNA LEVELS ON THE RATE OF ALT NORMALIZATION DURING ANTIVIRAL THERAPY WITH ENTECAVIR OR TENOFOVIR DISOPROXIL FUMARATE FOR CHRONIC HEPATITIS B
    Choi, Jonggi
    Choi, Won-Mook
    Lim, Young-Suk
    HEPATOLOGY, 2020, 72 : 486A - 486A